Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants.

Clinical and translational science·2026

Same author

Effect of Visualized Respiratory Training on Patient Cooperation and Image Quality in Gadoxetic Acid Disodium-Enhanced Liver MRI: A Randomized Controlled Trial.

Journal of magnetic resonance imaging : JMRI·2026

Same author

AI-Assisted Prostate Cancer Diagnosis Using Biparametric MRI and PI-RADS v2.1: Performance Comparison Between Novice-Level and Experienced Readers.

Journal of magnetic resonance imaging : JMRI·2026

Same author

Photocurable robust gelatin-based hydrogel with strong tissue adhesion for wound closure.

Acta biomaterialia·2026

Same author

Macrophage metabolic reprogramming in sepsis-associated acute lung injury: mechanisms and therapeutic strategies.

Frontiers in immunology·2026

Same author

Cas13-Mediated RNA Base Editing for the Treatment of Hereditary Hypertrophic Cardiomyopathy.

Circulation·2026

Search research articles

Related Experiment Video

Updated: Sep 14, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Precision sniper for solid tumors: CAR-NK cell therapy.

Sisi Li^1,2, Jiajie Jing¹, Yueming Chen¹

¹Department of Clinical Medicine, Hangzhou City University School of Medicine, 51 Huzhou Street, Hangzhou, 310015, People's Republic of China.

Cancer Immunology, Immunotherapy : CII

|July 24, 2025

Summary

This summary is machine-generated.

Chimeric antigen receptor-Natural Killer (CAR-NK) cell therapy shows promise for solid tumors, offering potential advantages over CAR-T cells by reducing toxicity. This review covers CAR-NK design, production, and challenges.

Keywords:

CAR-NK Immunotherapy Solid tumors Targeted therapy

More Related Videos

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Related Experiment Videos

Last Updated: Sep 14, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

Area of Science:

Immunotherapy
Oncology
Cellular Engineering

Background:

Chimeric antigen receptor-T (CAR-T) cell therapy is effective for hematologic cancers but limited in solid tumors due to toxicity.
Natural Killer (NK) cells offer a broader source and potential for reduced side effects compared to T cells.

Purpose of the Study:

To review recent advancements in CAR-NK cell therapy for solid tumors.
To focus on CAR-NK cell design, production methods, and associated challenges.

Main Methods:

Comprehensive review of in vivo and in vitro studies on CAR-NK therapy.
Analysis of laboratory and clinical evidence regarding CAR-NK cell technology.

Main Results:

CAR-NK therapy presents a promising alternative for solid tumor treatment.
CAR-NK cells may mitigate some toxicities associated with CAR-T cell therapy.

Conclusions:

CAR-NK cell therapy is an evolving field with significant potential for solid tumors.
Further research is needed to overcome challenges and optimize CAR-NK cell design and application.